Novo Nordisk AS ADR (NVO) 股票價格和圖表 | 立即交易

交易 Novo Nordisk AS ADR - NVO 差價合約

Headquartered in Denmark, Novo Nordisk employs approximately 42,100 people in 79 countries and markets its products in more than 170 countries worldwide. The company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. Operating through two business segments, including diabetes and obesity care, and biopharmaceuticals. The company’s diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The company’s biopharmaceuticals segment covers the therapy areas of haemophilia care, growth hormone therapy and hormone replacement therapy. Novo Nordisk’s insulin and other pharmaceutical products are marketed and distributed through subsidiaries, distributors and independent agents with responsibility for specific geographical areas. With Capital.com you stay in sync with the latest info on the Novo Nordisk (NVO) share price.